Amgen Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 239 trades in Amgen Inc (NASDAQ: AMGN) since 2014, across 49 members, worth an estimated $4.8M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 136 buys against 103 sells, a modestly buy-led skew, with Democratic members responsible for 59% of the trades and Republican members 41%. The most recent disclosure shown was filed April 2026, and Ro Khanna has filed the most AMGN transactions among those shown, with 4. Other recent filers include Maria Elvira Salazar, David J. Taylor, and Marjorie Taylor Greene. One notable disclosed move was a purchase by Lisa Mcclain on June 24, 2025, up 31.9% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Amgen Inc (AMGN) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Amgen congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
 Ro Khanna House | Apr 7, 2026 | Mar 30, 2026 | 8 days | SELL |  $15,001 - $50,000 | +2.55% | |
 Maria Elvira Salazar House | Apr 21, 2026 | Mar 24, 2026 | 28 days | BUY | $15,001 - $50,000 | +2.71% | |
 David J. Taylor House | Mar 6, 2026 | Feb 26, 2026 | 8 days | SELL | $1,001 - $15,000 | -5.65% | |
Ro Khanna House | Mar 9, 2026 | Feb 24, 2026 | 13 days | BUY | $15,001 - $50,000 | -6.53% | |
David J. Taylor House | Feb 2, 2026 | Jan 29, 2026 | 4 days | SELL | $1,001 - $15,000 | +5.08% | |
Ro Khanna House | Feb 6, 2026 | Jan 23, 2026 | 14 days | SELL | $15,001 - $50,000 | +4.53% | |
David J. Taylor House | Feb 2, 2026 | Jan 16, 2026 | 17 days | BUY | $1,001 - $15,000 | +9.07% | |
David J. Taylor House | Dec 5, 2025 | Dec 3, 2025 | 2 days | SELL | $1,001 - $15,000 | +4.33% | |
| Oct 28, 2025 | Oct 24, 2025 | 4 days | BUY | $1,001 - $15,000 | +24.39% | ||
Ro Khanna House | Oct 3, 2025 | Sep 29, 2025 | 4 days | SELL | $1,001 - $15,000 | +32.47% |
Amgen (AMGN) congressional trading FAQ
Can members of Congress legally trade Amgen (AMGN) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Amgen (AMGN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Amgen (AMGN) trades public?
Yes. Every congressional trade in Amgen (AMGN) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Amgen (AMGN)?
Members of Congress have disclosed 239 trades in Amgen (AMGN) worth $4.8M across 49 members, according to public STOCK Act filings.
Which members of Congress have traded Amgen (AMGN)?
Recent and active filers of Amgen (AMGN) disclosures include Ro Khanna, David J. Taylor, Marjorie Taylor Greene. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Amgen (AMGN) more?
Across disclosed Amgen (AMGN) trades, 59% were by Democrats and 41% by Republicans, led by Democrats (59%).
What is the most recent congressional Amgen (AMGN) trade?
The most recent disclosed Amgen (AMGN) trade was a purchase by Maria Elvira Salazar, filed Apr 20, 2026.
Browse all stocks Congress tradesCongressional trading overviewAmgen (AMGN) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.